Clinical Edge Journal Scan

Meta-analysis Identifies Atopic Dermatitis as Potential Risk Factor for Headache Disorder or Migraine


 

Key clinical point: Atopic dermatitis (AD) is significantly associated with a higher risk for headache disorders or migraine.

Major finding: Patients with AD had a significantly higher risk for headache disorder (odds ratio [OR] 1.46; 95% CI 1.36-1.56) or migraine (OR 1.32; 95% CI 1.18-1.47; both P < .001). This finding was consistent across the different subgroup analyses.

Study details : The data come from a meta-analysis of 10 observational studies that evaluated the risk for headache disorders in 12,717,747 patients with AD, of which six studies evaluated migraine risk in 11,090,412 patients with AD.

Disclosures: This study was supported by the project of training talent for Zhejiang province young and middle-aged clinical traditional Chinese medicine experts and Hangzhou Municipal Health and Family Planning Commission Science and Technology Project, China. The authors declared no conflicts of interest.

Source: Yang W, Dai H, Xu X-F, et al. Association of atopic dermatitis and headache disorder: A systematic review and meta-analyses. Front Neurol. 2024;15:1383832. doi: 10.3389/fneur.2024.1383832 Source

Recommended Reading

Commentary: Migraine and Cardiovascular Risk, April 2024
Migraine ICYMI
Tension, Other Headache Types Robustly Linked to Attempted, Completed Suicide
Migraine ICYMI
First Long-Term Data on Atogepant for Migraine Prevention
Migraine ICYMI
IV Ketamine Promising for Severe Refractory Headache in Children
Migraine ICYMI
Vaporized Cannabis for Acute Migraine Yields Rapid, Sustained Relief
Migraine ICYMI
Lidocaine Nerve Block Effective for Severe, Refractory Migraine in Children
Migraine ICYMI
High-Dose Eicosapentaenoic Acid as a Promising Prophylactic Treatment for Episodic Migraine
Migraine ICYMI
Early Erenumab Outperforms Non-specific Oral Treatments in Migraine Patients With Prior Treatment Failures
Migraine ICYMI
Positive Impact of Anti-CGRP Monoclonal Antibodies on Sleep Quality in Migraine
Migraine ICYMI
Patients With Chronic Kidney Disease Experiences Modestly Lower Risk for Migraine
Migraine ICYMI